๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Lamivudine for the prevention of hepatitis B virus reactivation in hbsag seropositive cancer patients undergoing cytotoxic chemotherapy

โœ Scribed by W Yeo; W.M Ho; P Hui; C.K Lam; B Zee; W.H Kwan; P.K.S Chan; J.J Lee; P.J Johnson

Book ID
118622246
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
179 KB
Volume
2
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Lamivudine in the treatment of hepatitis
Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy
โœ Yeo, Winnie; Steinberg, Joyce L.; Tam, John S.; Chan, Paul K.S.; Leung, Nancy W. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 76 KB ๐Ÿ‘ 2 views

Hepatitis B virus (HBV) reactivation has been described in cancer patients who received cytotoxic/immunosuppressive therapy and may result in liver damage of varying degrees of severity. There is no known effective treatment. Lamivudine, a nucleoside analogue, has been found to suppress HBV replicat